Sign in
GNPX Stock Price, Chart, Stats & News
Genprex, Inc.
Save
Genprex, Inc. (GNPX) does not currently pay a dividend.
823,427
Market cap
–
Current P/E
–
Forward P/E
GNPX chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -470.71% |
ROE | -877.16% |
D/E | – |
Interest coverage ratio | – |
GNPX valuation
P/E | – |
P/S | – |
P/B | 1.80x |
P/CF | -0.09x |
P/FCF | -0.20x |
P/OCF | -0.09x |
PEG | -0.00x |
EV multiple | -0.24x |
About
Genprex, Inc. is a biotechnology firm specializing in gene therapy, with its primary focus on advancing treatments through clinical stages. Their mission revolves around developing innovative therapies for patients battling cancer and diabetes. Leading their product pipeline is REQORSA (GPX-001), a flagship gene therapy candidate specifically designed to target both non-small cell lung cancer and small cell lung cancer.
Similar securities
Based on sector and market capitalization
Report issue